Abstract:T-cell antigen receptors (TCRs) exhibit inherent cross-reactivity which broadens the spectrum of epitopes that are recognizable by a finite TCR-repertoire but also carries the risk of autoimmunity. However, TCRs support also a high level of antigen specificity as they allow T-cells to discriminate single antigenic peptide/MHC complexes (pMHCs) against millions of structurally related self-pMHCs, in some cases based on the absence or presence of a single methyl-group. How TCRs manage to convey such seemingly contrary properties and why some T-cells become over time autoreactive despite negative thymic selection, has remained elusive. Here, we devised a non-invasive molecular live cell imaging platform to investigate the biophysical parameters governing stimulatory TCR:pMHC interactions in settings of autoreactivity and anti-viral responses - two extremes in T-cell antigen recognition. We show that CMV-specific CD8+ RA14-T-cells respond effectively to even a single HLA-A2/CMV (A2/CMV) antigen, with synaptic TCR:pMHC lifetimes lasting seconds. In contrast, cross-reactivity of type 1 diabetes (T1D)-associated CD8+ 1E6 T-cells towards HLA-A2/preproinsulin (A2/PPI) self-epitopes involved ten-fold less stable synaptic TCR interactions resulting in severely attenuated ZAP70 recruitment and downstream signaling. Compared to A2/CMV-engaged RA14 T-cells, 1E6-T-cells required for activation 4000 or more A2/PPI and at least 100-times as many simultaneously pMHC-engaged TCRs. In support of antigen discrimination, CD8 co-engagement of MHC class I (MHCI) strengthened both settings of TCR:pMHC interactions equally but was essential only for sensitized virus detection but not autorecognition (1000- versus 5-fold enhancement). We conclude that the binding dynamics of TCRs and CD8 with pMHC shape the boundaries of central tolerance in the physiological context of the phenomenal yet also differential T-cell antigen detection capacity, TCR-cross-reactivity and self-antigen abundance. Gained insights are integral to a molecular and quantitative understanding of CD8+ T-cell mediated autoimmunity and protective immunity against infections and cancer.

CD4 T cell antigen discovery

De novo identification of CD4 + T cell epitopes

TCR beta Chain Repertoire Characteristic between Healthy Human CD4+ and CD8+ T Cells

Deciphering CD4+ T cell specificity using novel MHC–TCR chimeric receptors

CD4+ T cell epitope identification de novo

Study for complementarity determining region 3 of T cell receptor beta chain in infectious diseases

Molecular Characterization Of T-Cell Antigen Receptor Expression By Subsets Of Cd4- Cd8- Murine Thymocytes

High Affinity Xenoreactive TCR:MHC Interaction Recruits CD8 in Absence of Binding to MHC1

Large-scale statistical mapping of T-cell receptor sequences to Human Leukocyte Antigens

CD4 Function epitope and antagonist: their research advances

HLAs, TCRs, and KIRs, a Triumvirate of Human Cell-Mediated Immunity

The Many Faces of CD4+ T Cells: Immunological and Structural Characteristics

Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis

Human CD8+ T lymphocyte clones specific for T cell receptor Vβ families expressed on autologous CD4+ T cells

Exploring the pre-immune landscape of antigen-specific T cells

T-cell virtuosity in ''knowing thyself"

Crystal structure of a complete ternary complex of T-cell receptor, peptide–MHC, and CD4

Deconstructing CTL-mediated autoimmunity through weak TCR-cross-reactivity towards highly abundant self-antigen

T cell receptor repertoire deciphers anti-tuberculosis immunity

T-FINDER: A highly sensitive, pan-HLA platform for functional T cell receptor and ligand discovery

Antigen identification for HLA class I– and HLA class II–restricted T cell receptors using cytokine-capturing antigen-presenting cells